Table 1.
Socio-demographic data for the complete dataset
| No. of patients | |
|---|---|
| Country | |
| Belgium | 222 |
| Denmark | 247 |
| France | 116 |
| Germany | 254 |
| Hungary | 171 |
| Italy | 517 |
| Netherlands | 209 |
| Norway | 468 |
| Poland | 247 |
| Russia | 269 |
| Spain | 274 |
| Turkey | 280 |
| UK | 268 |
| Most common diagnoses | |
| Psoriasis | 484 |
| Eczema | 239 |
| Acne | 185 |
| No. of patients | Average age (years, range) | |
|---|---|---|
| All subjects | 3542 | 46.29 (18–95) |
| Sex | ||
| Male (n) | 1558 | 47.76 (18–92) |
| Female (n) | 1984 | 45.14 (18–95) |
| Average DLQI scorea | 6.69 | |
| EQ-5D domain (no. of patients) | No problems | Some problems | Extreme problems |
|---|---|---|---|
| Mobility | 2692 | 839 | 11 |
| Self-care | 3162 | 372 | 8 |
| Usual activities | 2615 | 874 | 53 |
| Pain or discomfort | 1604 | 1739 | 199 |
| Anxiety or depressed | 1954 | 1431 | 157 |
aDLQI total score range is 0–30, 0 indicating no impairment and 30 indicating maximum impairment of quality of life